<DOC>
	<DOCNO>NCT01922843</DOCNO>
	<brief_summary>The goal study test new vitamin D compound ability reduce parathyroid hormone level patient hemodialysis .</brief_summary>
	<brief_title>A Phase 2 Study Oral Vitamin D Compound ( DP001 ) Secondary Hyperparathyroidism Patients Hemodialysis</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled study vitamin D analog 2-methylene-19-nor-20S-1α,25-dihydroxyvitamin D3 ( DP001 ) patient end-stage renal disease ( ESRD ) . The effect 12 week oral administration DP001 serum parathyroid hormone ( PTH ) level evaluate ESRD patient secondary hyperparathyroidism .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<criteria>Men nonpregnant woman ≥18 year age Patient diagnose ESRD must hemodialysis 3 time per week least 3 month prior Screening Phase Patient currently treat pharmaceutical vitamin D treatment secondary hyperparathyroidism Serum iPTH value ≤500 pg/mL first screen visit Total serum calcium ( correct albumin ) ≤10.5 mg/dL first screen visit Serum phosphorus ≤7.0 mg/dL first screen visit Currently take follow : drug affect vitamin D metabolism , digitalis , glucocorticoid , cyclosporine immunosuppressant , aluminumbased phosphate binder A daily intake &gt; 4000 IU vitamin D ( D3 + D2 ) Any investigational drug use within 10 halflives drug ( within previous 30 day halflife drug unknown ) History follow : ventricular dysrhythmias , severe congestive heart failure , angina pectoris , myocardial infarction , coronary angioplasty , coronary artery bypass grafting , multiple myeloma , calciphylaxis , active malignancy , endstage liver disease , active infection , clinically significant renal/urinary tract stone , sarcoidosis , tuberculosis , parathyroidectomy Major surgery within past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Hemodialysis</keyword>
</DOC>